In 21st centuary, cellular and gene therapies are becoming increasingly dominant treatment methods. In this context, Celgentera, Biomedical, Pharmaceutical and Health Services Ltd., is poised to become a leading company in Turkey, providing a variety of consumables, devices, and services as a supply chain for cellular and gene therapies
To supply the best consumables and devices or instruments to our customers for cell therapy or gene therapies
Cellular therapies can be defined as the use of cells to treat diseases. Cellular therapies generally involve injecting, grafting, or transplanting living cells into a patient. Various cellular therapies exist in this context. In stem cell therapies, stem cells are used to repair affected tissue. Because stem cells can differentiate into various cell types, they are used for cellular therapy of the tissue being repaired. In recent years, exosome therapies have also been used for purposes similar to cell therapy. These therapies utilize exosomes derived from cells rather than cells themselves. Immunotherapies can also be classified as cellular therapies. Various immunotherapies are used. In this context, adoptive T-cell therapies (tumor-infiltrating lymphocyte (TIL) therapy), dendritic cell therapies, Car-T and Car-NK therapies, or Car-TCR therapies are known as cellular immunotherapies. Cellular therapies are also combined with genetic therapies to form "cell and gene" therapy. In this case, genetically modified cells are used in cellular therapies. Cellular therapies can be performed using cells from a healthy donor (allogeneic) or the patient's own cells (autologous).